Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Healthcare ETF Vanguard (NY: VHT )

275.42 -0.01 (-0.01%)
Streaming Delayed Price Updated: 1:50 PM EDT, Jul 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125,080
Open 275.43
Bid (Size) 275.36 (2)
Ask (Size) 275.45 (4)
Prev. Close 275.43
Today's Range 274.47 - 276.27
52wk Range 222.27 - 278.06
Shares Outstanding 661,004
Dividend Yield 1.27%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Applying These 11 Stock Market Sectors Will Help Diversify Your Portfolio
There is a classification system that separates the +5,000 publicly traded U.S. stocks into 11 sectors representing key areas of the economy. Choosing the right sectors can be a challenge so this... 
Via Talk Markets
Topics Economy
Exposures Economy
2 Vanguard Funds Perfectly Positioned for the AI Revolution
Artificial intelligence will radically transform these two sectors in less than a decade. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+8.18%
+8.18%
1 Month
+3.54%
+3.54%
3 Month
+7.36%
+7.36%
6 Month
+7.10%
+7.10%
1 Year
+11.35%
+11.35%

More News

Read More
Want $1 Million in Retirement? 2 ETFs to Buy Now and Hold for Decades
Via The Motley Fool
Topics ETFs Retirement
Exposures Pension
Should You Buy Vanguard's Hottest Sector-Based ETF?
Via The Motley Fool
8 Trillion Reasons to Buy and Hold This Vanguard ETF
Via The Motley Fool
Topics ETFs
10 Best Vanguard Funds to Buy Right Now
Via The Motley Fool
Topics ETFs
Can Ocugen Stock Keep Churning Higher?
Via The Motley Fool
EXCLUSIVE: Pharma's Cloud Revolution — A $60B Market By 2030 With 1 Stock To Watch
Via Benzinga
Worried About a Market Correction? These 2 Defensive Vanguard Funds Are Pefect Safe Havens.
Via The Motley Fool
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
Via Benzinga
S&P 500 Stuck In 4600-4800 Limbo For 2024? Wells Fargo Pinpoints 3 'Favored Sectors' For Next Year
Via Benzinga
Topics Stocks
Exposures US Equities
Analysis: Autoworkers Are A Missing Piece In The October Jobs Report. Here's Why That Matters.
Via Benzinga
Bull Market or Recession? 2 Resilient Index Funds That Are Proven Moneymakers to Buy Now and Hold Forever (No Matter What Comes Next)
Via The Motley Fool
Lab-Developed Tests Under FDA Scrutiny: What It Means For Startups
Via Benzinga
Exposures Product Safety
These Market Experts See a Downturn Coming: 2 Defensive Index Funds That Are Proven Moneymakers to Buy Now
Via The Motley Fool
Protect Your Portfolio and Rotate Into Healthcare Stocks Now
Via InvestorPlace
5 ETFs Responding To PPI Surge And Consumer Sentiment Dip On Friday
Via Benzinga
Topics ETFs
'Headwinds Are Substantial': Jamie Dimon Just Flagged A Long List Of Serious Dangers To The US Economy — Here Are 3 'Salient' Risks And How To Defend Against Them
Via Benzinga
From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
Via Benzinga
The 3 Best Healthcare Stocks to Buy for June 2023
Via InvestorPlace
Don't "Sell In May And Go Away", Consider 5 ETF Strategies
Via Talk Markets
6 Best Healthcare Stocks to Buy Right Now
Via MarketBeat
Topics Economy Intellectual Property
Exposures Economy Intellectual Property Product Safety
The 7 Best Investment Funds to Navigate a Possible Recession
Via InvestorPlace
7 Investments to FIRE Up a Fat Stash and Retire Early
Via InvestorPlace
Highest ESG Score ETFs Index Down 0.7% In August; Now Down 12.6% YTD
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.